Tissue-Type Plasminogen Activator has Paradoxical Roles in Focal Cerebral Ischemic Injury by Thrombotic Middle Cerebral Artery Occlusion with Mild or Severe Photochemical Damage in Mice
Open Access
- 1 June 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 22 (6) , 648-651
- https://doi.org/10.1097/00004647-200206000-00002
Abstract
The role of endogenous tissue-type plasminogen activator (tPA) in focal cerebral ischemic injury (FCII) after middle cerebral artery occlusion was studied using tPA gene-deficient (KO) mice and their wild-type (WT) littermates. The middle cerebral artery was occluded by thrombi induced by three different intensities of photochemical damage, a method that was newly introduced in mice. In both WT and KO mice, the intensity-dependent increase of FCII size was observed. The FCII size in tPA WT mice was smaller than in KO mice in cases of mild damage, whereas the FCII size was larger in WT mice than in KO mice in cases of severe damage. There was no difference in FCII size between WT and KO mice in cases of moderate damage. The number of microthrombi also increased with damage intensity in both WT and KO mice, but was less in WT mice at all intensities of damage. The results support the validity of the model of thrombotic occlusion by photochemical damage in mice, and suggest that endogenous tPA protects FCII through thrombolytic action on transient occlusion of middle cerebral artery with mild damage, but deteriorates on persistent occlusion with severe damage.Keywords
This publication has 17 references indexed in Scilit:
- The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signalingNature Medicine, 2001
- Serine Protease Inhibitors: Novel Therapeutic Targets for Stroke?Journal of Cerebral Blood Flow & Metabolism, 2000
- Tissue Plasminogen Activator (tPA) Deficiency Exacerbates Cerebrovascular Fibrin Deposition and Brain Injury in a Murine Stroke ModelArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Role of Plasminogen System Components in Focal Cerebral Ischemic InfarctionCirculation, 1999
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activatorNature, 1995
- Effect of Argatroban on Microthrombi Formation and Brain Damage in the Rat Middle Cerebral Artery Thrombosis ModelThe Japanese Journal of Pharmacology, 1995
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model.Stroke, 1993
- A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this modelJournal of Pharmacological and Toxicological Methods, 1993